- $1.20bn
- $1.39bn
- $796.85m
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million
GoodRx Holdings Inc expected to post earnings of 8 cents a share - Earnings Preview
Brief: GoodRx Holdings Q1 Adjusted Net Income USD 23 Million Vs. IBES Estimate USD 24.7 Million
Brief: Goodrx Expands Offerings To Now Include Ozempic® Pill For Type 2 Diabetes Patients
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman
Amazon to stock Lilly's new weight-loss pill at US kiosks, offer same-day delivery (updated)
U.S. STOCKS ON THE MOVE-Zscaler, Carlyle, Weight Watchers
U.S. STOCKS ON THE MOVE-Marvell Technology, Tempus AI, Energy Vault
GoodRx rises after offering Lilly weight-loss drugs at discounted self-pay prices
Viatris rises as it teams up with GoodRx to offer discounts on brand‑name drugs
Brief: Goodrx To Expand Employer-Sponsored Access To Zepbound® Kwikpen®
Lilly launches employer-connect platform to broaden weight-loss drug access (updated)
Lilly launches employer-connect platform to broaden weight-loss drug access
U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler
GoodRx Q4 revenue slightly beats estimates, helped by Pharma Direct growth
Brief: GoodRx Holdings Q4 Adjusted Net Income USD 29 Million Vs. IBES Estimate USD 32 Million